PMID: 11905640Mar 22, 2002Paper

Haemopoietic stem-cell transplantation: recent progress and future promise

The Lancet Oncology
C Craddock

Abstract

Transplantation of haemopoietic stem cells is an increasingly important approach in the management of malignant haematological disease. Recent developments in our understanding of stem-cell biology have profoundly influenced the practice of both autologous and allogeneic stem cell transplantation. The demonstration that cytokines, such as granulocyte colony-stimulating factor, mobilise large numbers of haemopoietic progenitors has resulted in the peripheral blood rather than the bone marrow becoming the preferred source of haemopoietic stem cells in autologous, and increasingly in allogeneic, stem-cell transplantation. This has substantially reduced the morbidity of autografting, so that disease relapse now represents the most important cause of treatment failure. Current efforts are aimed at reducing this risk, either by employing novel conditioning regimens or by tumour purging. With regard to allogeneic transplantation, there is a growing realisation of the importance of a graft-versus-leukaemia effect, and this has encouraged the use of strategies which optimise an immunologically-mediated antitumour effect. This, coupled with increased understanding of the biology of stem-cell engraftment, has resulted in the development o...Continue Reading

References

Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·T PapayannopoulouN S Wolf
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Papayannopoulou, B Nakamoto
Sep 1, 1996·Southern Medical Journal·I A Tabbara
Apr 1, 1997·Bone Marrow Transplantation·S CoubanJ Meharchand
Nov 1, 1996·Current Opinion in Hematology·J E Dick
Apr 2, 1998·The New England Journal of Medicine·J A HansenC Anasetti
Dec 19, 1998·British Journal of Haematology·N H RussellN Schmitz
Jun 3, 1999·The New England Journal of Medicine·E C GuinanJ G Gribben
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·D BonnetS R Riddell
Oct 3, 1999·The New England Journal of Medicine·E C Tramont
Oct 6, 1999·Current Opinion in Immunology·E W PetersdorfJ A Hansen
Dec 22, 1999·British Journal of Haematology·D C Linch, A H Goldstone

❮ Previous
Next ❯

Citations

Jul 13, 2002·The Journal of Pathology·W R Otto
Mar 12, 2002·Archives of Medical Research·Pedro Sobrevilla-CalvoAlejandro Marché-Cova
Jun 20, 2003·European Urology·Ivar BleumerPeter F A Mulders
Jul 9, 2004·Transplantation·Galen E SwitzerDennis L Confer
Mar 4, 2006·International Journal of Hematology·Masahiro ImamuraYoshihisa Kodera
Oct 15, 2003·Clinical Lymphoma·Tommy AlainAnna E Kossakowska
Jan 18, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Helmut Borberg
Apr 7, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Crystal Y KohWilliam J Murphy
May 10, 2012·PLoS Computational Biology·Christos A Ouzounis
Oct 1, 2016·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Aseem Kumar TiwariAshok Kumar Vaid
Dec 21, 2004·Expert Review of Anticancer Therapy·John S LamRobert A Figlin
Mar 23, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GratwohlUNKNOWN Working Party on Solid Tumors
Nov 2, 2004·Bone Marrow Transplantation·A GratwohlUNKNOWN Accreditation Committee of the European Group for Blood and Marrow Transplantation
Nov 16, 2004·Bone Marrow Transplantation·P MorandiV Fosser
Sep 10, 2005·Bone Marrow Transplantation·A GratwohlUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Feb 4, 2003·Nature Reviews. Immunology·Peter Parham, Karina L McQueen
May 17, 2003·Leukemia·A GratwohlUNKNOWN Lymphoma Working Party
Aug 1, 2008·Expert Review of Cardiovascular Therapy·Brent Anderson, Douglas B Sawyer
Dec 14, 2004·Stem Cells and Development·Nagwa S El-BadriPaul R Sanberg
Oct 5, 2001·The American Journal of Pathology·J S SandhuD A Shafritz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
G A Decker, S L Nyberg
© 2022 Meta ULC. All rights reserved